BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6688611)

  • 1. Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
    Murray F; Daly PA; Freyne PJ
    Ir J Med Sci; 1983 Jul; 152(7):286-8. PubMed ID: 6688611
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
    Blijham GH; Vermeulen A; Mendes de Leon DE
    Cancer; 1985 Nov; 56(9):2292-4. PubMed ID: 3840407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood Hodgkin's disease.
    Ekert H
    J Clin Oncol; 1991 Mar; 9(3):528-9. PubMed ID: 1999723
    [No Abstract]   [Full Text] [Related]  

  • 4. [Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
    Sciascia R; Albisinni U; Ammendolia I; Barbieri E; Tondi L
    Radiol Med; 1989 Apr; 77(4):336-41. PubMed ID: 2471231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W; Drzewoski J; Robak T; Krykowski E
    Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
    Virgolini L; De Maglio A
    Ital J Orthop Traumatol; 1992; 18(4):543-6. PubMed ID: 1345650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aseptic necrosis of the femur head as a complication of intensive cytostatic, glucocorticoid and radiation therapy of lymphogranulomatosis].
    Semenov II; Gershanovich ML; Artiushkin AV
    Vopr Onkol; 1984; 30(2):35-9. PubMed ID: 6546632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
    Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
    Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary toxicity secondary to procarbazine.
    Mahmood T; Mudad R
    Am J Clin Oncol; 2002 Apr; 25(2):187-8. PubMed ID: 11943900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
    Casini M; Pianezze G; Fabris P; Cemin S; Coser P
    Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
    [No Abstract]   [Full Text] [Related]  

  • 14. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
    Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
    Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
    Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
    J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
    Mantovani G; Del Giacco GS; Marongiu F; Tognella S; Carassi UE
    Acta Haematol; 1982; 67(4):287-8. PubMed ID: 6810628
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary toxicity following MOPP chemotherapy.
    Millward MJ; Cohney SJ; Byrne MJ; Ryan GF
    Aust N Z J Med; 1990 Jun; 20(3):245-8. PubMed ID: 2196871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.